|A hand affected by rheumatoid arthritis, an autoimmune form of arthritis|
|Classification and external resources|
Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness, warmth, swelling, and decreased range of motion of the affected joints. In some types other organs are also affected. Onset can be gradual or sudden.
There are over 100 types of arthritis. The most common forms are osteoarthritis (degenerative joint disease) and rheumatoid arthritis. Osteoarthritis usually occurs with age and affects the fingers, knees, and hips. Rheumatoid arthritis is an autoimmune disorder that often affects the hands and feet. Other types include gout, lupus, fibromyalgia, and septic arthritis. They are all types of rheumatic disease.
Treatment may include resting the joint and alternating between applying ice and heat. Weight loss and exercise may also be useful. Pain medications such as ibuprofen and paracetamol (acetaminophen) may be used. In some a joint replacement may be useful.
Osteoarthritis affects more than 3.8% of people while rheumatoid arthritis affects about 0.24% of people. Gout affects about 1 to 2% of the Western population at some point in their lives. In Australia and the United States more than 20% of people have a type of arthritis. Overall the disease becomes more common with age. Arthritis is a common reason that people miss work and can result in a decreased quality of life. The term is from Greek arthro- meaning joint and -itis meaning inflammation.
- 1 Classification
- 2 Prevalence
- 3 Signs and symptoms
- 4 Diagnosis
- 5 Treatment
- 6 Epidemiology
- 7 History
- 8 Terminology
- 9 See also
- 10 References
- 11 External links
There are several diseases where joint pain is primary, and is considered the main feature. Generally when a person has "arthritis" it means that they have one of these diseases, which include:
- Rheumatoid arthritis
- Gout and pseudo-gout
- Septic arthritis
- Ankylosing spondylitis
- Juvenile idiopathic arthritis
- Still's disease
Joint pain can also be a symptom of other diseases. In this case, the arthritis is considered to be secondary to the main disease; these include:
- Psoriasis (Psoriatic arthritis)
- Reactive arthritis
- Ehlers-Danlos Syndrome
- Lyme disease
- Sjogren's disease
- Hashimoto's Thyroiditis
- Celiac disease
- Non-celiac gluten sensitivity
- Inflammatory bowel disease (including Crohn's disease and ulcerative colitis)
- Henoch–Schönlein purpura
- Hyperimmunoglobulinemia D with recurrent fever
- Whipple's disease
- TNF receptor associated periodic syndrome
- Granulomatosis with polyangiitis (and many other vasculitis syndromes)
- Familial Mediterranean fever
- Systemic lupus erythematosus
Disability due to musculoskeletal disorders increased by 45% from 1990 to 2010. Of these, osteoarthritis is the fastest increasing major health condition. Among the many reports on the increased prevalence of musculoskeletal conditions, data from Africa are lacking and underestimated. A systematic review assessed the prevalence of arthritis in Africa and included twenty population-based and seven hospital-based studies. The majority of studies, twelve, were from South Africa. Nine studies were well-conducted, eleven studies were of moderate quality, and seven studies were conducted poorly. The results of the systematic review were as follows:
- Rheumatoid arthritis: 0.1% in Algeria (urban setting); 0.6% in Democratic Republic of Congo (urban setting); 2.5% and 0.07% in urban and rural settings in South Africa respectively; 0.3% in Egypt (rural setting), 0.4% in Lesotho (rural setting)
- Osteoarthritis: 55.1% in South Africa (urban setting); ranged from 29.5 to 82.7% in South Africans aged 65 years and older
- Knee osteoarthritis has the highest prevalence from all types sites of osteoarthritis, with 33.1% in rural South Africa
- Ankylosing spondylitis: 0.1% in South Africa (rural setting)
- Psoriatic arthritis: 4.4% in South Africa (urban setting)
- Gout: 0.7% in South Africa (urban setting)
- Juvenile idiopathic arthritis: 0.3% in Egypt (urban setting)
Signs and symptoms
|Extra-articular features of joint disease|
|Cutaneous vasculitis lesions|
|Tenosynovitis (tendon sheath effusions)|
|Bursitis (swollen bursa)|
Pain, which can vary in severity, is a common symptom in virtually all types of arthritis. Other symptoms include swelling, joint stiffness and aching around the joint(s). Arthritic disorders like lupus and rheumatoid arthritis can affect other organs in the body, leading to a variety of symptoms. Symptoms may include:
- Inability to use the hand or walk
- Stiffness, which may be worse in the morning, or after use
- Malaise and fatigue
- Weight loss
- Poor sleep
- Muscle aches and pains
- Difficulty moving the joint
It is common in advanced arthritis for significant secondary changes to occur. For example, arthritic symptoms might make it difficult for a person to move around and/or exercise, which can lead to secondary effects, such as:
These changes, in addition to the primary symptoms, can have a huge impact on quality of life.
Arthritis is the most common cause of disability in the USA. More than 20 million individuals with arthritis have severe limitations in function on a daily basis. Absenteeism and frequent visits to the physician are common in individuals who have arthritis. Arthritis can make it very difficult for individuals to be physically active and some become home bound.
It is estimated that the total cost of arthritis cases is close to $100 billion of which almost 50% is from lost earnings. Each year, arthritis results in nearly 1 million hospitalizations and close to 45 million outpatient visits to health care centers.
Decreased mobility, in combination with the above symptoms, can make it difficult for an individual to remain physically active, contributing to an increased risk of obesity, high cholesterol or vulnerability to heart disease. People with arthritis are also at increased risk of depression, which may be a response to numerous factors, including fear of worsening symptoms.
|This section does not cite any sources. (January 2015) (Learn how and when to remove this template message)|
Diagnosis is made by clinical examination from an appropriate health professional, and may be supported by other tests such as radiology and blood tests, depending on the type of suspected arthritis. All arthritides potentially feature pain. Pain patterns may differ depending on the arthritides and the location. Rheumatoid arthritis is generally worse in the morning and associated with stiffness; in the early stages, patients often have no symptoms after a morning shower. Osteoarthritis, on the other hand, tends to be worse after exercise. In the aged and children, pain might not be the main presenting feature; the aged patient simply moves less, the infantile patient refuses to use the affected limb.
Elements of the history of the disorder guide diagnosis. Important features are speed and time of onset, pattern of joint involvement, symmetry of symptoms, early morning stiffness, tenderness, gelling or locking with inactivity, aggravating and relieving factors, and other systemic symptoms. Physical examination may confirm the diagnosis, or may indicate systemic disease. Radiographs are often used to follow progression or help assess severity.
Blood tests and X-rays of the affected joints often are performed to make the diagnosis. Screening blood tests are indicated if certain arthritides are suspected. These might include: rheumatoid factor, antinuclear factor (ANF), extractable nuclear antigen, and specific antibodies.
Osteoarthritis is the most common form of arthritis. It can affect both the larger and the smaller joints of the body, including the hands, wrists, feet, back, hip, and knee. The disease is essentially one acquired from daily wear and tear of the joint; however, osteoarthritis can also occur as a result of injury. In recent years, some joint or limb deformities, such as knock-knee or acetabular overcoverage or dysplasia, have also been considered as a predisposing factor for knee or hip osteoarthritis. Osteoarthritis begins in the cartilage and eventually causes the two opposing bones to erode into each other. The condition starts with minor pain during physical activity, but soon the pain can be continuous and even occur while in a state of rest. The pain can be debilitating and prevent one from doing some activities. Osteoarthritis typically affects the weight-bearing joints, such as the back, knee and hip. Unlike rheumatoid arthritis, osteoarthritis is most commonly a disease of the elderly. More than 30 percent of women have some degree of osteoarthritis by age 65. Risk factors for osteoarthritis include prior joint trauma, obesity, and a sedentary lifestyle.
Rheumatoid arthritis (RA) is a disorder in which the body's own immune system starts to attack body tissues. The attack is not only directed at the joint but to many other parts of the body. In rheumatoid arthritis, most damage occurs to the joint lining and cartilage which eventually results in erosion of two opposing bones. RA often affects joints in the fingers, wrists, knees and elbows, is symmetrical (appears on both sides of the body), and can lead to severe deformity in a few years if not treated. RA occurs mostly in people aged 20 and above. In children, the disorder can present with a skin rash, fever, pain, disability, and limitations in daily activities. With earlier diagnosis and aggressive treatment, many individuals can lead a better quality of life than if going undiagnosed for long after RA's onset. The drugs to treat RA range from corticosteroids to monoclonal antibodies given intravenously. Treatments also include analgesics such as NSAIDs and disease-modifying antirheumatic drugs (DMARDs), while in rare cases, surgery may be required to replace joints, but there is no cure for the disease.
Treatment with DMARDs is designed to initiate an adaptive immune response, in part by CD4+ T helper (Th) cells, specifically Th17 cells. Th17 cells are present in higher quantities at the site of bone destruction in joints and produce inflammatory cytokines associated with inflammation, such as interleukin-17 (IL-17).
Bone erosion is a central feature of rheumatoid arthritis. Bone continuously undergoes remodeling by actions of bone resorbing osteoclasts and bone forming osteoblasts. One of the main triggers of bone erosion in the joints in rheumatoid arthritis is inflammation of the synovium, caused in part by the production of pro-inflammatory cytokines and receptor activator of nuclear factor kappa B ligand (RANKL), a cell surface protein present in Th17 cells and osteoblasts. Osteoclast activity can be directly induced by osteoblasts through the RANK/RANKL mechanism.
Lupus is a common collagen vascular disorder that can be present with severe arthritis. Other features of lupus include a skin rash, extreme photosensitivity, hair loss, kidney problems, lung fibrosis and constant joint pain.
Gout is caused by deposition of uric acid crystals in the joint, causing inflammation. There is also an uncommon form of gouty arthritis caused by the formation of rhomboid crystals of calcium pyrophosphate known as pseudogout. In the early stages, the gouty arthritis usually occurs in one joint, but with time, it can occur in many joints and be quite crippling. The joints in gout can often become swollen and lose function. Gouty arthritis can become particularly painful and potentially debilitating when gout cannot successfully be treated. When uric acid levels and gout symptoms cannot be controlled with standard gout medicines that decrease the production of uric acid (e.g., allopurinol, febuxostat) or increase uric acid elimination from the body through the kidneys (e.g., probenecid), this can be referred to as refractory chronic gout or RCG.
Comparison of types
|Osteoarthritis||Rheumatoid arthritis||Gouty arthritis|
|Speed of onset||Months||Weeks-months||Hours for an attack|
|Main locations||Weight-bearing joints (such as knees, hips, vertebral column) and hands||Hands (proximal interphalangeal and metacarpophalangeal joint) wrists, ankles, knees and hips||Great toe, ankles, knees and elbows|
|Inflammation||May occur, though often mild compared to inflammation in rheumatoid arthritis||Yes||Yes|
|Laboratory findings||None||Anemia, elevated ESR and C-reactive protein (CRP), rheumatoid factor, anti-citrullinated protein antibody||Crystal in joints|
Infectious arthritis is another severe form of arthritis. It presents with sudden onset of chills, fever and joint pain. The condition is caused by bacteria elsewhere in the body. Infectious arthritis must be rapidly diagnosed and treated promptly to prevent irreversible joint damage.
Psoriasis can develop into psoriatic arthritis. With psoriatic arthritis, most individuals develop the skin problem first and then the arthritis. The typical features are of continuous joint pains, stiffness and swelling. The disease does recur with periods of remission but there is no cure for the disorder. A small percentage develop a severe painful and destructive form of arthritis which destroys the small joints in the hands and can lead to permanent disability and loss of hand function.
There is no known cure for either rheumatoid or osteoarthritis. Treatment options vary depending on the type of arthritis and include physical therapy, lifestyle changes (including exercise and weight control), orthopedic bracing, and medications. Joint replacement surgery may be required in eroding forms of arthritis. Medications can help reduce inflammation in the joint which decreases pain. Moreover, by decreasing inflammation, the joint damage may be slowed.
In general, studies have shown that physical exercise of the affected joint can noticeably improve long-term pain relief. Furthermore, exercise of the arthritic joint is encouraged to maintain the health of the particular joint and the overall body of the person.
Individuals with arthritis can benefit from both physical and occupational therapy. In arthritis the joints become stiff and the range of movement can be limited. Physical therapy has been shown to significantly improve function, decrease pain, and delay need for surgical intervention in advanced cases. Exercise prescribed by a physical therapist has been shown to be more effective than medications in treating osteoarthritis of the knee. Exercise often focuses on improving muscle strength, endurance and flexibility. In some cases, exercises may be designed to train balance. Occupational therapy can provide assistance with activities as well as equipment.
There are several types of medications that are used for the treatment of arthritis. Treatment typically begins with medications that have the fewest side effects with further medications being added if insufficiently effective.
Depending on the type of arthritis, the medications that are given may be different. For example, the first-line treatment for osteoarthritis is acetaminophen (paracetamol) while for inflammatory arthritis it involves non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Opioids and NSAIDs are less well tolerated.
Rheumatoid arthritis (RA) is autoimmune so in addition to using pain medications and anti-inflammatory drugs, this type uses another category of drug called disease modifying anti-rheumatic drugs (DMARDS). An example of this type of drug is Methotrexate. These types of drugs act on the immune system and slow down the progression of RA.
A number of rheumasurgical interventions have been incorporated in the treatment of arthritis since the 1950s. Arthroscopic surgery for osteoarthritis of the knee provides no additional benefit to optimized physical and medical therapy.
A Cochrane review in 2000 concluded that transcutaneous electrical nerve stimulation (TENS) for knee osteoarthritis was more effective in pain control than placebo.[needs update]Low level laser therapy may be considered for relief of pain and stiffness associated with arthritis. Evidence of benefit is tentative.
Pulsed electromagnetic field therapy has tentative evidence supporting improved functioning but no evidence of improved pain in osteoarthritis. The FDA has not approved PEMF for the treatment of arthritis. In Canada, PEMF devices are legally licensed by Health Canada for the treatment of pain associated with arthritic conditions.
Arthritis is predominantly a disease of the elderly, but children can also be affected by the disease. More than 70% of individuals in North America affected by arthritis are over the age of 65. Arthritis is more common in women than men at all ages and affects all races, ethnic groups and cultures. In the United States a CDC survey based on data from 2007–2009 showed 22.2% (49.9 million) of adults aged ≥18 years had self-reported doctor-diagnosed arthritis, and 9.4% (21.1 million or 42.4% of those with arthritis) had arthritis-attributable activity limitation (AAAL). With an aging population, this number is expected to increase.
Evidence of osteoarthritis and potentially inflammatory arthritis has been discovered in dinosaurs. The first known traces of human arthritis date back as far as 4500 BC. In early reports, arthritis was frequently referred to as the most common ailment of prehistoric peoples. It was noted in skeletal remains of Native Americans found in Tennessee and parts of what is now Olathe, Kansas. Evidence of arthritis has been found throughout history, from Ötzi, a mummy (circa 3000 BC) found along the border of modern Italy and Austria, to the Egyptian mummies circa 2590 BC.
The word 'arthritides' denoting the collective group of arthritis-like conditions.
- Arthritis Care (charity in the UK)
- Arthritis Foundation (US not-for-profit)
- Knee arthritis
- Weather pains
- "Arthritis and Rheumatic Diseases". NIAMS. October 2014. Retrieved 14 September 2016.
- "Arthritis Types". CDC. June 22, 2016. Retrieved 14 September 2016.
- "Living With Arthritis: Health Information Basics for You and Your Family". NIAMS. July 2014. Retrieved 14 September 2016.
- "Arthritis Basics". CDC. May 9, 2016. Retrieved 14 September 2016.
- Athanasiou, Kyriacos A.; Darling, Eric M.; Hu, Jerry C.; DuRaine, Grayson D.; Reddi, A. Hari (2013). Articular Cartilage. CRC Press. p. 105. ISBN 9781439853252.
- "Arthritis". CDC. July 22, 2015. Retrieved 14 September 2016.
- "Arthritis: An Overview". OrthoInfo. October 2007. Retrieved 14 September 2016.
- March, L; Smith, EU; Hoy, DG; Cross, MJ; Sanchez-Riera, L; Blyth, F; Buchbinder, R; Vos, T; Woolf, AD (June 2014). "Burden of disability due to musculoskeletal (MSK) disorders.". Best practice & research. Clinical rheumatology. 28 (3): 353–66. PMID 25481420.
- Richette P, Bardin T (January 2010). "Gout". Lancet. 375 (9711): 318–28. doi:10.1016/S0140-6736(09)60883-7. PMID 19692116.
- Pirotta, M (September 2010). "Arthritis disease - the use of complementary therapies.". Australian family physician. 39 (9): 638–40. PMID 20877766.
- Waite, Maurice (2012). Paperback Oxford English Dictionary. OUP Oxford. p. 35. ISBN 9780199640942. Missing
|last1=in Authors list (help)
- Guandalini S, Assiri A (Mar 2014). "Celiac disease: a review". JAMA Pediatr. 168 (3): :272–8. doi:10.1001/jamapediatrics.2013.3858. PMID 24395055.
- Fasano A, Sapone A, Zevallos V, Schuppan D (May 2015). "Nonceliac gluten sensitivity". Gastroenterology. 148 (6): 1195–204. doi:10.1053/j.gastro.2014.12.049. PMID 25583468.
- Volta U, Caio G, De Giorgio R, Henriksen C, Skodje G, Lundin KE (Jun 2015). "Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders". Best Pract Res Clin Gastroenterol. 29 (3): 477–91. doi:10.1016/j.bpg.2015.04.006. PMID 26060112.
- Catassi C, Bai J, Bonaz B, Bouma G, Calabrò A, Carroccio A, Castillejo G, Ciacci C, Cristofori F, Dolinsek J, Francavilla R, Elli L, Green P, Holtmeier W, Koehler P, Koletzko S, Meinhold C, Sanders D, Schumann M, Schuppan D, Ullrich R, Vécsei A, Volta U, Zevallos V, Sapone A, Fasano A (2013). "Non-celiac gluten sensitivity: the new frontier of gluten related disorders". Nutrients (Review). 5 (10): 3839–3853. doi:10.3390/nu5103839. ISSN 2072-6643. PMC . PMID 24077239.
- Wollenhaupt J, Zeidler H (1998). "Undifferentiated arthritis and reactive arthritis". Current opinion in rheumatology. 10 (4): 306–313. doi:10.1097/00002281-199807000-00005. PMID 9725091.
- GBD 2010 Country, Collaboration (23 March 2013). "GBD 2010 country results: a global public good". Lancet (London, England). 381 (9871): 965–70. doi:10.1016/S0140-6736(13)60283-4. PMID 23668561.
- Usenbo, Anthony; Kramer, Veronika; Young, Taryn; Musekiwa, Alfred; Nurmohamed, Michael (4 August 2015). "Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis". PLoS ONE. 10 (8): e0133858. doi:10.1371/journal.pone.0133858. PMC . PMID 26241756.
- Swash, M, Glynn, M. (eds). 2007. Hutchison's Clinical Methods. Edinburgh. Saunders Elsevier.
- Arthritis: The Nation’s Most Common Cause of Disability Centers for disease prevention and health promotion. Retrieved on 2010-01-24
- Arthritis: The Nation's Most Common Cause of Disability The Center for Disease Control. Retrieved on 2015-01-04
- "Direct and Indirect Costs of Musculoskeletal Conditions in 1997: Total and Incremental Estimates Revised Final Report (July, 2003)". Retrieved 6 April 2016.
- "Rheumatoid Arthritis and Heart Disease Risk: Atherosclerosis, Heart Attacks, and More". Retrieved 2015-06-09.
- "Coping With Depression and Rheumatoid Arthritis". Retrieved 2015-06-09.
- "How is arthritis diagnosed? | Arthritis Research UK". www.arthritisresearchuk.org. Retrieved 2015-06-09.
- VanItallie TB (October 2010). "Gout: epitome of painful arthritis". Metab. Clin. Exp. 59 (Suppl 1): S32–6. doi:10.1016/j.metabol.2010.07.009. PMID 20837191.
- Medications used to manage rheumatoid arthritis, Australian Institute Of Health And Welfare. Retrieved 2015-11-14.
- Kurebayashi Y, Nagai S, Ikejiri A, Koyasu S (2013). "Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells". Genes Cells. 18 (4): 247–65. doi:10.1111/gtc.12039. PMC . PMID 23383714.
- Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P (2000). "Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis". Cytokine. 12 (7): 1092–9. doi:10.1006/cyto.2000.0681. PMID 10880256.
- Won HY, Lee JA, Park ZS, Song JS, Kim HY, Jang SM, Yoo SE, Rhee Y, Hwang ES, Bae MA (2011). "Prominent bone loss mediated by RANKL and IL-17 produced by CD4+ T cells in TallyHo/JngJ mice". PLoS ONE. 6 (3): e18168. doi:10.1371/journal.pone.0018168. PMC . PMID 21464945.
- Rheumatoid Arthritis: Differential Diagnoses & Workup~diagnosis at eMedicine
- Becker, Michael A. (2005). Arthritis and Allied Conditions: A textbook of Rheumatology edition 15. Lippincot Williams & Wilkins. pp. 2303–2339.
- Ali S, Lally EV (November 2009). "Treatment failure gout". Medicine and health, Rhode Island. 92 (11): 369–71. PMID 19999896.
- Unless otherwise specified in table box, the reference is: Agabegi, Elizabeth D.; Agabegi, Steven S. (2008). "Table 6–7". Step-Up to Medicine. Step-Up Series. Hagerstwon MD: Lippincott Williams & Wilkins. p. 253. ISBN 0-7817-7153-6.
- Diagnosis lag time of median 4 weeks, and median diagnosis lag time of 18 weeks, taken from: Chan KW, Felson DT, Yood RA, Walker AM (1994). "The lag time between onset of symptoms and diagnosis of rheumatoid arthritis". Arthritis and rheumatism. 37 (6): 814–820. doi:10.1002/art.1780370606. PMID 8003053.
- Schaider, Jeffrey; Wolfson, Allan B.; Gregory W Hendey; Louis Ling; Carlo L Rosen (2009). Harwood-Nuss' Clinical Practice of Emergency Medicine (Clinical Practice of Emergency Medicine (Harwood-Nuss)). Hagerstwon, MD: Lippincott Williams & Wilkins. pp. 740 (upper right of page). ISBN 0-7817-8943-5.
- Severe Arthritis Disease Facts Retrieved on 2010-02-05
- Psoriatic Arthritis Mayo Clinic. Retrieved on 2010-02-05
- Ettinger WH, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, Shumaker S, Berry MJ, O'Toole M, Monu J, Craven T (1997). "A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST)". JAMA: the Journal of the American Medical Association. 277 (1): 25–31. doi:10.1001/jama.1997.03540250033028. PMID 8980206.
- Fransen M, Crosbie J, Edmonds J (January 2001). "Physical therapy is effective for patients with osteoarthritis of the knee: a randomized controlled clinical trial". J. Rheumatol. 28 (1): 156–64. PMID 11196518.
- "Arthritis Drugs". arthritistoday.org. Archived from the original on 22 July 2010. Retrieved July 5, 2010.
- Reid MC, Shengelia R, Parker SJ (Mar 2012). "Pharmacologic management of osteoarthritis-related pain in older adults". The American journal of nursing. 112 (3 Suppl 1): S38–43. doi:10.1097/01.NAJ.0000412650.02926.e3. PMC . PMID 22373746.
- Kirkley A, Birmingham TB, Litchfield RB, Giffin JR, Willits KR, Wong CJ, Feagan BG, Donner A, Griffin SH, D'Ascanio LM, Pope JE, Fowler PJ (2008). "A randomized trial of arthroscopic surgery for osteoarthritis of the knee". N. Engl. J. Med. 359 (11): 1097–107. doi:10.1056/NEJMoa0708333. PMID 18784099.
- Osiri M, Welch V, Brosseau L, Shea B, McGowan J, Tugwell P, Wells G (2000). "Transcutaneous electrical nerve stimulation for knee osteoarthritis". Cochrane Database Syst Rev (4): CD002823. doi:10.1002/14651858.CD002823. PMID 11034768.
- Brosseau L, Welch V, Wells G, Tugwell P, de Bie R, Gam A, Harman K, Shea B, Morin M (2000). "Low level laser therapy for osteoarthritis and rheumatoid arthritis: a meta-analysis". The Journal of Rheumatology. 27 (8): 1961–1969. PMID 10955339.
- Brosseau, L; Welch, V; Wells, G; DeBie, R; Gam, A; Harman, K; Morin, M; Shea, B; Tugwell, P (2004). "Low level laser therapy (Classes I, II and III) for treating osteoarthritis". The Cochrane database of systematic reviews (3): CD002046. doi:10.1002/14651858.CD002046.pub2. PMID 15266461.
- Brosseau, L; Robinson, V; Wells, G; Debie, R; Gam, A; Harman, K; Morin, M; Shea, B; Tugwell, P (19 October 2005). "Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis". The Cochrane database of systematic reviews (4): CD002049. doi:10.1002/14651858.CD002049.pub2. PMID 16235295.
- Vavken, P; Arrich, F; Schuhfried, O; Dorotka, R (May 2009). "Effectiveness of pulsed electromagnetic field therapy in the management of osteoarthritis of the knee: a meta-analysis of randomized controlled trials.". Journal of rehabilitation medicine. 41 (6): 406–11. PMID 19479151.
- Walsh (7 October 2010). "One in Five Adults Has Arthritis". MedPage Today.
based on Centers for Disease Control and Prevention (CDC) (October 2010). "Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation – United States, 2007–2009". MMWR Morb. Mortal. Wkly. Rep. 59 (39): 1261–5. PMID 20930703.
- Joel A. DeLisa; Bruce M. Gans; Nicholas E. Walsh (2005). Physical Medicine and Rehabilitation: Principles and Practice. Lippincott Williams & Wilkins. pp. 765–. ISBN 978-0-7817-4130-9.
- Blumberg BS, Sokoloff L (1961). "Coalescence of caudal vertebrae in the giant dinosaur Diplodocus". Arthritis Rheum. 4: 592–601. PMID 13870231.
- Bridges PS (1992). "Prehistoric Arthritis in the Americas". Annual Review of Anthropology. 21: 67–91. doi:10.1146/annurev.an.21.100192.000435.
- Arthritis History Medical News
- Alick Cameron, "Musgrave, William (1655–1721)", Oxford Dictionary of National Biography, Oxford University Press, Sept 2004
- Arthritis at DMOZ
- American College of Rheumatology – US professional society of rheumatologists
- National Institute of Arthritis and Musculoskeletal and Skin Diseases - US National Institute of Arthritis and Musculoskeletal and Skin Diseases